Introduction
Ceramide plays a central role in sphingolipid biosynthesis and catabolism and is composed of sphingosine and a fatty acid. As a bioactive lipid, ceramide has been implicated in a variety of physiological functions including apoptosis and cell growth arrest, differentiation, senescence, migration, and adhesion (Hannun and Obeid 2008) . Roles for ceramide as a cell-death-inducing factor have also been suggested in a number of pathological conditions including cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity, and inflammation (Wu et al. 2007; Zeidan and Hannun 2007) . Moreover, ceramide involvement has been suggested in cochlear hair cell loss induced by gentamicin through apoptosis .
Two main ceramide generation pathways are known: via hydrolysis of sphingomyelin at the plasma membrane or via de novo biosynthesis in cells involving the action of the enzymes serine palmitoyltransferase (SPT) and ceramide synthase (Pewzner-Jung et al. 2006) . Because ceramide shows toxicity against the cochlea, we supposed that generation of ceramide through the above-mentioned synthesis pathways may affect hair cell damage.
Sphingomyelin is hydrolyzed to ceramide by three types of sphingomyelinases (acid, neutral, and alkaline) . Of these, magnesium-dependent neutral sphingomyelinase (nSMase) has been identified as a prime candidate for ceramide synthesis. Although three nSMases (nSMase1, nSMase2, and nSMase3) exist (Hofmann et al. 2000; Krut et al. 2006; Tomiuk et al. 1998) , nSMase2 is responsible for most of the nSMase activity in many organs and thus is the principal Abstract Ceramide, a sphingolipid metabolite, regulates diverse cellular processes including apoptosis, cell senescence, the cell cycle, and cellular differentiation. Exogenously administered ceramide reportedly increased cochlear hair cell death due to gentamicin-induced ototoxicity. Ceramide is mainly generated via a ceramide/sphingomyelin cycle by sphingomyelinase and sphingomyelin synthase or via de novo synthesis by serine palmitoyltransferase and ceramide synthase. This study was designed to investigate the possible involvement of neutral sphingomyelinase, sphingomyelin synthase, or serine palmitoyltransferase in hair cell death due to gentamicin. The basal turns of the organ of Corti of Sprague-Dawley rats were dissected on postnatal days 3-5. Cochlear cultures were exposed to media containing 35 μM gentamicin for 48 h to assess the effects of GW4869 (a neutral sphingomyelinase inhibitor), 2-hydroxyoleic acid (a sphingomyelin synthase activator), and myriocin (a serine palmitoyltransferase inhibitor). Hair cell loss was significantly decreased in the presence of GW4869 or 2-hydroxyoleic acid. Myriocin had no significant effects against gentamicin-induced hair cell loss. In addition, neutral sphingomyelinase was activated by gentamicin exposure. The present findings strongly suggest that the ceramide/ sphingomyelin cycle plays an important role in the protection of hair cells against gentamicin-induced ototoxicity.
generator of ceramide (Aubin and Guenet 2005; Stoffel et al. 2005) . Overexpression of nSMase2 in hepatocytes reportedly resulted in a 40 % decrease in SM levels and a concomitant 60 % increase in ceramide levels (Karakashian et al. 2004; Marchesini et al. 2003) . Although ceramide augments the apoptotic death of outer hair cells , whether nSMase is involved in ceramide generation in gentamicin-induced ototoxicity has not been revealed.
Sphingomyelin synthase (SMS) can also potentially regulate ceramide levels. SMS reconverts ceramide produced by nSMase to sphingomyelin. Namely, catalysis by nSMase and SMS forms a ceramide/sphingomyelin cycle. However, the role of this cycle has not yet been reported.
In the de novo ceramide biosynthesis pathway, SPT is the first and rate-limiting enzyme. Ceramide generation is derived from the de novo biosynthesis pathway by coordinated activation of SPT and ceramide synthase, an endpoint catalyst of ceramide production.
Considering a possible role of ceramide in gentamicininduced ototoxicity, we hypothesized that hair cell loss could be prevented by modifying the ceramide biosynthesis pathways. In this study, we examined the functions of nSMase, SMS, and SPT in gentamicin-induced ototoxicity.
Materials and methods

Organ of Corti collection
The basal turns of the organ of Corti were dissected from Sprague-Dawley rats on postnatal days 3-5 and cultured according to the methods of Van de Water and Ruben (1974) and Sobkowicz et al. (1993) . All animal procedures were carried out according to the guidelines of the Laboratory Animal Research Center of the University of Tsukuba.
Culture techniques
Cochlear explants were maintained in Dulbecco's modified Eagle's medium with 10 % fetal bovine serum (FBS), 25 mM HEPES, and 30 U/mL penicillin and cultured in an incubator at 37 °C with 5 % CO2 and 95 % humidity. Cochlear cultures were maintained in the above-described medium overnight (8-12 h) and then exposed to a medium containing 35 μM gentamicin for 48 h to assess the effects of sphingolipid metabolites Nishimura et al. 2010; Tabuchi et al. 2007 ).
Pharmacological treatments GW4869 (an nSMase inhibitor), 2-hydroxyoleic acid (2OHOA, an SMS activator), and myriocin (an SPT inhibitor) were purchased from Sigma, Japan (Tokyo, Japan). The tested concentrations of GW4869, 2OHOA, and myriocin were 1-50 μM, 10 nM-100 μM, and 1 pM-50 μM, respectively. The tested concentrations were determined based on the previous experiments on the neuronal cells, vascular smooth muscle cells, fibroblasts, glioma cells, lung adenocarcinoma cells, and liver cells (Babenko and Kharchenko 2012; Cubi et al. 2013; Liao et al. 2013; Martin et al. 2013; Qin et al. 2012 ). The highest concentration of myriocin was determined at 50 μM because of its solubility. GW4869 was routinely stored at −80 °C as a stock suspension of 1.5 mM in dimethyl sulfoxide (DMSO; Sigma, St Louis, MO, USA). Immediately before use, the suspension was solubilized by addition of 5 % methane sulfonic acid (MSA; Sigma). The suspension was mixed and warmed at 37 °C until clear (Luberto et al. 2002) . 2OHOA was dissolved in DMSO at a stock concentration of 25 mg/ mL and stored at −20 °C. Myriocin was dissolved in methanol at a stock concentration of 2 mg/mL and stored at −20 °C.
Cytochemistry
After 48-h culture, the explants were fixed with 4 % paraformaldehyde in phosphate-buffered saline (PBS) for 20 min and then permeabilized with 5 % Triton X-100 (Sigma) in PBS with 10 % FBS for 10 min Tabuchi et al. 2007 Tabuchi et al. , 2010 . The specimens were stained with phalloidin with a conjugated Alexa Fluor phalloidin probe (1:100; Molecular Probes, Carlsbad, CA, USA) at room temperature for 1 h. Phalloidin is a specific marker for cellular F-actin and labels the stereociliary arrays and cuticular plates of hair cells Tabuchi et al. 2007) .
Hair cells were characterized as missing if no stereocilia and/or no cuticular plate was observed by phalloidin staining. Quantitative results were obtained by evaluating 30 outer hair cells associated with 10 inner hair cells in a given microscopic field Tabuchi et al. 2007 ). The average of three separate counts was used to represent each culture.
Immunostaining of hair cells by anti-nSMase2 antibody
Rabbit polyclonal anti-nSMase2 (H-195) (sc-67305) was purchased from Santa Cruz Biotechnology (Dallas, TX, USA), and donkey anti-rabbit FITC (711-095-152), from Sigma.
The hair cells were removed from the culture media, rinsed twice in PBS, and fixed in 4 % paraformaldehyde for 20 min and then double-immunostained. After removal of the fixative, the cells were incubated in 0.1 % Triton X-100 and 10 % FBS at room temperature for 15 min.
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The primary anti-nSMase2 antibody was diluted 1:100 in PBS and incubated with cells overnight at 4 °C. After six rinses in PBS for 5 min each at room temperature, cells were incubated with FITC-conjugated secondary antibody (diluted 1:100 in PBS) for 45 min in a dark chamber and then rinsed extensively in PBS at room temperature. The specimens were stained with phalloidin with a conjugated Alexa Fluor phalloidin probe (1:100) at room temperature for 1 h. One drop of SlowFade Gold antifade reagent (Invitrogen, Carlsbad, CA, USA) was added, and the slide was sealed with nail polish. The immunofluorescence reaction was followed and documented with an Axiophot microscope (Carl Zeiss, Oberkochen, Germany).
nSMase assay nSMase activity of the basal turn of the organ of Corti cells during gentamicin exposure was measured using an nSMase assay kit (K-1800; Echelon, Salt Lake City, UT, USA) as described in the manufacturer's protocol. Briefly, organ of Corti cells were harvested and washed with PBS. After the cells had been homogenized, 60 μg total protein was used to examine the nSMase activity. One hundred microliters of samples was mixed with 100 μL reaction buffer and 5 mM dithiothreitol (Thermo Scientific, Rockford, IL, USA) to block any acid sphingomyelinase activity. The samples were incubated at 37 °C for 4 h. The enzymatic activity was calculated from the graph's slope of the absorbance of light at 595 nm against the concentration of sphingomyelinase and standardized by milligrams of protein (mU/mg, representing the specific enzymatic activity).
Data analyses and statistics
All data were expressed as the means ± SEMs. Statistical analysis was performed using unpaired t tests or one-way analysis of variance (ANOVA) followed by Bonferroni post hoc tests, as required (StatView 5.0). Probability (p) values below 0.05 were considered significant.
Results
Expression of nSMase2 in cochlear hair cells
Immunostaining of nSMase2 in organ of Corti cells revealed the presence of nSMase2 in the inner and outer hair cells (Fig. 1) .
GM activated nSMase in organ of Corti cells
Changes in nSMase activity during gentamicin exposure were examined using the organ of Corti explants. Twenty minutes after the initiation of gentamicin exposure, enzymatic activity of the hair cell extracts significantly increased (n = 6 samples of protein, p < 0.001) to nearly threefold those of the non-gentamicin controls. Thereafter, nSMase activity gradually declined, but at 48 h, the level of nSMase activity was significantly (n = 6, p < 0.001) higher (344 %) than that of the non-gentamicin controls (one-way ANOVA and Bonferroni post hoc test; Fig. 2 ). 
Control pharmacological study
Before the gentamicin experiments, the effects on hair cells of 1-50 μM GW4869, 10 nM-100 μM 2OHOA, and 1 pM-50 μM myriocin, and of 0.01 % MSA, 0.25 % DMSO, and 1 % methanol as solvents were examined. In the control explants maintained in the media containing these agents for 48 h without exposure to gentamicin, almost all hair cells, in both the inner and the outer rows, were present. Namely, hair cell loss was not statistically significant when explants were cultured for 48 h in the media containing each agent without gentamicin (data not shown). Furthermore, we also confirmed that the hair cell loss did not differ significantly between the explants exposed to media containing 35 μM gentamicin with 0.01 % MSA, 0.25 % DMSO, or 1 % methanol for 48 h and those exposed to media containing 35 μM gentamicin alone (data not shown). 
Inhibition of nSMase protected hair cells against gentamicin-induced ototoxicity The effects of GW4869, an nSMase inhibitor, on gentamicin-induced hair cell damage were examined. GW4869 significantly decreased outer hair cell loss induced by gentamicin at 35 μM (n = 12 explants, p = 0.03), 40 μM (n = 15, p < 0.001), 45 μM (n = 13, p < 0.001), and 50 μM (n = 16, p < 0.001) when compared with the control group exposed to gentamicin alone (one-way ANOVA and Bonferroni post hoc test; Fig. 3 ).
Activation of SMS protected hair cells against gentamicin-induced ototoxicity
The effects of 2OHOA, an SMS activator, on gentamicininduced hair cell damage were examined. 2OHOA significantly decreased outer hair cell loss induced by gentamicin at 10 μM (n = 11 explants, p < 0.001) and 100 μM (n = 15, p < 0.001) when compared with the control group exposed to GM alone (one-way ANOVA and Bonferroni post hoc test; Fig. 4 ).
Inhibition of SPT had no effect on gentamicin-induced hair cell loss
The effects of myriocin, an SPT inhibitor, on gentamicininduced hair cell damage were examined. Myriocin had no significant effect on the degree of hair cell survival at 1 pM-50 μM when compared with gentamicin alone (oneway ANOVA; Fig. 5 ).
Discussion
Ceramide has attracted great attention because of its possible roles in cochlear hair cell apoptosis . Better understanding of the ceramide formation system might offer relevant insights into cochlear hair cell death.
Our immunofluorescence study detected existence of nSMase2 in hair cells. Importantly, nSMase2 is responsible for the main function of nSMase (Aubin and Guenet 2005; Karakashian et al. 2004; Marchesini et al. 2003; Stoffel et al. 2005) . Additionally, gentamicin exposure increased the enzymatic activity of nSMase. GW4869, a specific inhibitor of nSMase, decreased gentamicininduced hair cell death. On the basis of these findings, ceramide generated by nSMase through the hydrolysis of sphingomyelin may be involved in gentamicin-induced ototoxicity.
In addition, activation of SMS by 2OHOA protected hair cells against gentamicin. Some researchers speculated on the existence of a ceramide/sphingomyelin cycle. In this cycle, nSMase hydrolyzes sphingomyelin to ceramide and SMS synthesizes sphingomyelin from ceramide. Thus, ceramide levels are balanced by the activities of these two enzymes. Our results suggested that such a ceramide/sphingomyelin cycle exists in the organ of Corti and that the balance in this cycle is important for determination of hair cell fate in gentamicin ototoxicity.
We have here documented, for the first time, the immunolocalization and enzymatic activity of nSMase in the cochlea. On the basis of the kinetics, the increase in enzymatic nSMase activity was divided into two phases. In the early phase, the total cellular nSMase activity increased by 292 % at 20 min of gentamicin exposure. Possibly, the nSMase activity rapidly increased as an initial response against gentamicin exposure. Thereafter, the nSMase activity gradually declined. In the late phase, at 48 h after gentamicin exposure, the level of nSMase activity was 344 % higher than that in the non-gentamicin-exposed controls.
In contrast to the results obtained with GW4869 and 2OHOA, myriocin, an SPT inhibitor, known as an inhibitor of the first enzyme in the de novo biosynthesis pathway, did not prevent hair cell death due to gentamicin-induced ototoxicity. This result indicated that the de novo generation of ceramide might not be involved in gentamicin-induced ototoxicity. However, several researchers reported that generation of ceramide via de novo biosynthesis occurred much more slowly than via the sphingomyelin hydrosis pathway (Bose et al. 1995; De Luca et al. 2005; Mullen et al. 2001 ).
Because our study examined results over a time course of 48 h, they may indicate that the de novo biosynthesis pathway is activated after a longer period.
In conclusion, the present findings strongly suggest the involvement of a ceramide/sphingomyelin cycle in gentamicin-induced cochlear ototoxicity. Gentamicin-induced ototoxicity may be ameliorated by modifying ceramide synthesis through this cycle.
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